Forward-thinking life sciences organizations have realized the benefits of AI-powered automation to transform their research and development operations, and streamline their path to market while enhancing patient safety.

But where are investments currently focused, for maximum strategic benefit?

Our new 2024 ArisGlobal Industry Report, Life Sciences R&D Transformation: Ambitions for Intelligent Automation & Today’s Reality, provides a timely deep-dive into the findings of our latest AI & Automation Industry Survey.

The research was conducted in late 2023 with 80+ organizations, spanning every patient treatment process domain, from top global pharmaceutical organizations to young biotechs.